Presentation on theme: "From Here to Where…? Prof Stephen Lawrie, Acting Director."— Presentation transcript:
From Here to Where…? Prof Stephen Lawrie, Acting Director
Outline Where are we now? – SMHRN team – Portfolio of adopted studies Where are we going? – Key challenge – Network’s renewed aims Why should you contact the Network? Under-funding of mental health research Future directions for the Network
Research Assistants: Emma Witt, Anna Peel, Sarah Browne & Lisa Blacklaw Chief Scientist Office Network Director: Stephen Lawrie Management Group: Andrew Gumley, Jonathan Cavanagh, Keith Matthews & Ross Hamilton Research Nurses: Lewis Harpin & Jacqueline McTaggart Study Co-ordinator: Laura Hodges Administrator: Amy Lambert Where are we now: The SMHRN team Advisory Board Associate Director: Gordon Murray Manager
Where are we now: Portfolio of adopted studies ProCEEDACTp* COBALTCBASP* CEQUELDOWNSLit* SMaRT Oncology-2GCIT* SMaRT Oncology-3 PilotResearch Register* SMaRT Oncology-3 EDIE-2 iMANTRA-R Bipolar High Risk Study PODS Brain Fitness Programme Deep Brain Stimulation * Adopted since 1 st October 2009
Where are we going? Key challenge : To facilitate the development, set-up and successful completion of large, well-funded research studies across Scotland.
Network’s renewed aims: Primary goals: – To increase the amount of mental health research – To increase the number of people participating in mental health research studies Broadening the scope: – Trials at various stages of development – Epidemiological, genetic and imaging studies – A broad view of health services research
Why should you contact the Network: (1) Adoptions Service Aim of the Adoptions Service is to support Study Set up and Completion SMHRN Adoptions Service help with Recruitment Data collection Regulation Site files / Master files Study documentation Statistical advice User Involvement
Why should you contact the Network: (2) Protocol Development Service Aim of the PDS is to encourage a pipeline of research SMHRN Protocol Development Service help with Focussing and refining the study question Development of the protocol Planning practical aspects of study execution Addressing regulatory requirements Making a power calculation and analysis strategy Identifying funding sources
Why should you contact the Network: (3) Protocol Development Groups Aim of PDGs is to bring together researchers with a shared interest in specific research questions Call for Applications for Protocol Development Groups Peer Review Funding to support PDG activity Methodological support Focus on producing high quality fundable research proposals
Supporting the current PDGs LeadResearch Area Kate DavidsonBorderline Personality Disorder Jane MorrisAnorexia Nervosa Alan CarsonFunctional Neurological Symptoms Andrew GumleyRecovery after Psychosis
Imbalance of resources Recent figures show that mental health research received 6.5% of the total research funding compared with 25% for research for cancer and 15% for neurological diseases. (Fair deal for mental health campaign, Royal College of Psychiatrists)
Cost of brain disorders in Europe* All brain disorders: €386b Health care costs: €135b Direct non-medical: €72b Indirect costs: €178b * Andlin-Sobocki P, Jonsson B et al. Eur J Neurol 2005, 12 Suppl 1:1-27 Mental Disorders inc. dementias €295b Neurological €84b Neurosurgical €7b Slides courtesy of Ian Ragan, Executive Director European Brain Council
Future directions for the Network (1) Focus on helping researchers develop their ideas for treatment trials and related studies by strengthening the Protocol Development Service. Actively encourage the development of PDGs in key areas such as depression (primary and secondary care), substance misuse and developmental disorders.
Future directions for the Network (2) Work more closely with: – The Mental Health Research Networks in England and Wales – Topic-specific Networks such as the Scottish Primary Care Research Network and the Scottish Dementia Research Network – NHS R&D Departments – Research organisations such as the WTCRFs
Future directions for the Network (3) Consult with: – Clinicians and researchers – Psychologists, psychiatrists, nurses, counsellors, physiotherapists… – Patients, carers and the public – Industry on how the Network can best engage and support them in research.